Skip to search formSkip to main contentSkip to account menu

EPI-743

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Reply to the letter to the editor by Josef Finsterer and Sinda Zarrouk-Mahjoub
2017
2017
EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
Objective: To evaluate the long-term safety and clinical effects of EPI-743 in Friedreich’s Ataxia (FRDA). Background: FRDA is an… 
2016
2016
EPI-743 (Quinone) therapy for Leber’s Hereditary Optic Neuropathy: the Brazil experience.
2015
2015
Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies
BACKGROUND AND PURPOSE: Brain white matter is frequently affected in mitochondrial diseases; optic atrophy gene 1-autosomal… 
Review
2015
Review
2015
ADULT BRAIN Diffusion Tensor ImagingMapping of BrainWhiteMatter Pathology inMitochondrial Optic Neuropathies
BACKGROUND AND PURPOSE: Brain white matter is frequently affected in mitochondrial diseases; optic atrophy gene 1-autosomal… 
2015
2015
Treatment of Leber's hereditary optic neuropathy with EPI‐743: the Brazilian experience
Purpose To determine the degree of visual improvement in a homogeneous Brazilian cohort of Leber's Hereditary Optic Neuropathy… 
2013
2013
Treatment of Leber's hereditary optic neuropathy (LHON): Results using a novel quinone, EPI-743
2013
2013
New concepts of treatment for LHON and other genetic mitochondrial optic neuropathies
In Leber’s Hereditary Optic Neuropathy (LHON), complex I impairment can lead to subacute loss of vision and optic nerve atrophy… 
2012
2012
A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich’s Ataxia Patients with Point Mutations
2010
2010
HD Therapeutics - CHDI Fifth Annual Conference.
  • Keith T. Gagnon
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 31583881
The CHDI Fifth Annual HD Therapeutics Conference, held in Palm Springs, CA, included topics covering new therapeutic developments… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)